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ASD closure performed between 2015 and 2017. 
The study population was divided into 2 groups: 
37 patients below 50 years of age (median 
[range] age, 34 [18–45] years) were included 
in group 1 and 37 patients above 50 years of 
age (median [range] age, 58 [50–72] years), in 
group 2. We collected data on selected clini­
cal characteristics, heart catheterization, and 
echocardiography results (TABLE 1). The balloon­
­stretched diameter of ASD was measured in 
24 patients from group 1 and 24 from group 2. 
Applying a  technique which was described 
elsewhere,6 the following atrial septal occlud­
ers were used: 40 Hyperion (Shanghai Shape 
Memory Alloy Co, Shanghai, China), 21 Heart 
R (Lifetech Scientific Corporation, Shenzen, 
China), 6 Cera (Lifetech Scientific Corporation, 
Shenzen, China), and 7 Cocoon (Vascular In­
novations, Nonthaburi, Thailand) occluders. 
To minimize nickel release to serum, the fol­
lowing occluders have different protective lay­
ers: preoxidized nitinol in Hyperion, titani­
um nitride in Cera, and platinum in Cocoon. 
The Heart R occluder is produced without any 
protective layer on the nitinol wire. The appli­
cation of the above mentioned devices depend­
ed on its availability (results of conducted ten­
ders). Patients in whom the ASO (Abbott Med­
ical, Plymouth, Minnesota, United States) and 
Figulla (Occlutech GmbH, Jena, Germany) oc­
cluders were used in this period were exclud­
ed from the study in order to ensure homoge­
neity of the sample.
Introduction Transcatheter closure of atri­
al septal defect (ASD) type II can be safely per­
formed in children and adults.1,2 Since the im­
plementation of the Amplatzer septal occluder 
(ASO) in 1997, many similar nitinol wire mesh 
Amplatzer ­like occluders have been developed. 
Nitinol is an alloy of nickel and titanium. Stud­
ies revealed a rise in nickel serum concentration, 
especially in the first 3 months after the ASO im­
plantation.3,4 To prevent this phenomenon as­
sociated with the use of several Amplatzer ­like 
occluders (also the ASO from 2014), different 
methods to pretreat nitinol wires were applied.
The  literature on the  use of Chinese and 
Thai occluders for percutaneous ASD closure 
is scarce.5 All these Amplatzer ­like occluders 
are very similar in shape, dimensions, struc­
ture of the delivery system, and the technique 
of implantation.
We described our experience with ASD clo­
sure in adults patients with the ASO devices 
elsewhere.6 However, to our best knowledge, this 
is the first study on ASD closure with the use 
of different nitinol wire devices (Chinese and 
Thai) with and without a protective nitinol layer.
Methods Between 1997 and 2018, over 1800 
patients (children and adults) underwent trans­
catheter closure of interatrial septum in our 
center, performed with different nitinol wire 
mesh occluders with and without a protective 
layer.5 In this study, we included 74 subsequent 
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Results and discussion Transcatheter ASD 
closure was successfully performed in 73 out 
of the 74 patients (98.6%). In 1 patient from 
group 1 with relatively large ASD (treated with 
the 30­mm Hyperion occluder), the procedure 
was discontinued due to unfavorable morphol­
ogy of the defect. The device was safely removed 
and the patient was referred for elective surgi­
cal closure of the defect.
While ASD (measured on transesophageal 
echocardiography) and applied devices’ diam­
eters were similar in both groups, mean pul­
monary arterial pressure (measured directly 
in the catheterization laboratory) was higher 
in older patients (group 2). Left ventricular ejec­
tion fraction was lower in group 2 (the difference 
was not significant) as shown in TABLE 1.
All nitinol wire mesh occluders (with and 
without a protective layer) were similarly effi­
cient with no difference in complication rate 
(no thrombosis, erosion, rupture, early or late 
embolization was observed). The fact that the de­
livery systems of Amplatzer ­like occluders are 
Patients were scheduled for a routine check ­up in 
the outpatient clinic 1, 6, and 12 months after ASD 
closure and yearly thereafter; 9 patients were lost 
to follow ­up. The median (range) follow ­up was 27 
(4–39) months. The researchers contacted patients 
by phone to assess their physical condition using 
the New York Heart Association (NYHA) class. Pa­
tients’ subjective view on that aspect was also elic­
ited by asking, among others, the question “How 
do you evaluate your physical well ­being after ASD 
closure?” with 5 possible answers: much better, bet­
ter, the same, worse, much worse. The study proto­
col was approved by the institutional review board.
Statistical analysis Statistical analysis was per­
formed with the use of the Statistica 12 software 
(TIBCO, Palo Alto, California, United States). 
P values less than 0.05 were considered signifi­
cant. Distribution of all variables was assessed 
with the Shapiro–Wilk test. Based on its results, 
the t test or Mann–Whitney test was used to 
compare numerical variables. Categorical vari­
ables were compared using the χ2 test.
TABLE 1 Selected clinical characteristics, data on heart catheterization, and echocardiography (before closure) 
in adult patients in whom atrial septal defect was closed percutaneously at the age below 50 years (group 1) 
or above (group 2) using nitinol wire mesh occluders with and without a protective layer
Parameter All patients Group 1 (n = 37) Group 2 (n = 37) P value
Age, y, median (min–max) 47.5 (18.9–72) 34 (18.9–45) 58 (50–72) <0.001
Female sex, n (%) 57 (77) 28 (75.7) 29 (78.4) 0.78
ASD diametera, mm, mean (SD) 17.6 (5.6) 17.42 (5.8) 17.67 (5.5) 0.86
Diameter after stretching, mm, 
mean (SD)
21.4 (5.49) 21.6 (5.7) 21.17 (5.36) 0.79
Device diameter, mm, mean (SD) 22.3 (6.3) 22.5 (7) 22.16 (5.73) 0.83
Fluoroscopy time, min, median 
(min–max)
3.9 (1.8–12) 4 (1.8–12) 3.8 (2–11) 0.7
mPAP, mm Hg, mean (SD) 18.1 (5.56) 16.32 (4.83) 20.28 (5.72) 0.007
RVD, cm, mean (SD) 3.6 (0.8) 3.4 (0.72) 3.75 (0.82) 0.08
LVEDD, cm, mean (SD) 4.4 (0.55) 4.32 (0.55) 4.47 (0.54) 0.25
RVD / LVEDD ratio, mean (SD) 0.83 (0.22) 0.80 (0.2) 0.85 (0.23) 0.43
LVEF, %, median (min–max) 68 (35–87) 71 (38–82) 65 (35–87) 0.18
Occluders without protectionb, 
n (%)
21 (28.4) 10 (27) 11 (29.7) 0.8
Occluders with protectionc, n (%) 53 (71.6) 27 (73) 26 (70.3) 0.8
Periprocedural complications, n (%) 3 (4.1) 1 (1.4)d 2 (2.7)e 0.56
a Measured on transesophageal echocardiography
b Occluders without a protective nitinol layer (Heart R)
c Occluders with a protective nitinol layer (Hyperion, Cera, Cocoon)
d  A patient with an arteriovenous fistula
e One patient with an extensive hematoma at the puncture site and 1 patient with pericardial tamponade treated with pericardial 
drainage
Abbreviations: ASD, atrial septal defect; LVEDD, left ventricular end ‑diastolic diameter; LVEF, left ventricular ejection fraction; mPAP, 
mean pulmonary artery pressure; RVD, right ventricular diameter
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of a nitinol occluder due to nickel allergy; how­
ever, patients with severe allergy might benefit 
from the implantation of different Amplatzer­
­like occluders with protective layers.
Limitations The  retrospective nature and 
the small number of patients are the main lim­
itations of our study.
Conclusions Transcatheter closure of ASD 
in adult patients below and above the  age 
of 50 years is a safe and effective procedure. 
The application of different Chinese and Thai 
nitinol wire occluders (with or without a pro­
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generally 2–3 F larger than those of the ASO 
is less important in adults than in preschool chil­
dren.1,5 The rates of periprocedural complications 
and procedural difficulties (reflected in the fluo­
roscopic time) were similar in both groups (TABLE 1). 
In group 2, there were 3 patients with mild resid­
ual shunt diagnosed after the procedure by trans­
thoracic echocardiography, which disappeared 
at 1­month follow ­up. We observed substantial 
cardiac remodeling that involved a decrease in 
the right ventricular diameter (RVD) and right 
to left ventricular end ­diastolic diameter ratio.
The mean (SD) decrease of the RVD was from 
3.43 (0.72) to 2.8 (0.6) cm in group 1 (t test, 
P <0.05) and from 3.75 (0.82) to 3.12 (0.7) cm 
in group 2 (t test, P <0.05). The right ventricu­
lar diameter (RVD) and right to left ventricu­
lar end­diastolic diameter ratio decreased from 
0.8 (0.2) to 0.62 (0.1) in group 1 (t test, P <0.05) 
and from 0.85 (0.2) to 0.69 (0.21) in group 
2 (t test, P <0.05).
After the procedure, the percentage of pa­
tients with NYHA class I raised from 28.6% 
to 82.1% in group 1 and from 9.5% to 66.7% 
in group 2.
Older patients (group 2) seemed to have a bet­
ter subjective opinion about the change in their 
physical function than younger adults; 60.7% 
of the patients in group 1 felt “better” or “much 
better” after ASD closure, whereas the same 
answers were given by 76.2% of the patients in 
group 2 (difference not significant).
Although safety and effectiveness of ASD clo­
sure in the elderly has already been document­
ed,6,7 all previous studies were based on the ASO 
devices. Moreover, our paper presents an un­
dervalued and rarely described7 aspect of phys­
ical function, cardiac remodeling, and quality of 
life after ASD closure in this population. To our 
best knowledge, there is no report that compares 
the safety and efficacy of ASD closure in young­
er and older adults performed with so many dif­
ferent devices.
Nickel allergy is estimated to be near 10% in 
the general population.3 Cases requiring explan­
tation of ASO were reported in the literature.4 
We have not observed any symptoms of nickel 
allergy in our cohort, although we used occlud­
ers with bare nitinol wires (Heart R) as well as 
with a protective layer (Hyperion, Cera, Cocoon). 
Skin allergy to nickel does not equate adverse 
effects after device implantation and the mech­
anism of intracardiac hypersensitivity to nick­
el differs from skin allergy.8 However, based on 
reports on acute reactions requiring explanta­
tion of the device,4 we believe that testing a skin 
reaction to nickel (in form of a nitinol occlud­
er worn as a necklace) in patients with known 
allergy is helpful in clinical practice. It may ex­
clude patients with severe allergy who might 
develop an acute reaction to the occluder. We 
did not report a case requiring the explantation 
